WEIGHT LOSS AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY: THE MULTIDISCIPLINARY APPROACH OF MAGGIORE DELLA CARITA’ AOU, NOVARA

Bariatric surgery is currently considered the most effective treatment to obtain a substantial weight loss sustained on the long term in morbid obesity. We present data regarding the recent bariatric experience of candidates enrolled between July 2016 and 2018 at “Maggiore Della Carità” Novara hospital. According to international and national guidelines1-2, surgery inclusion criteria were: age 8-65 years old; BMI ≥40 kg/m2 or ≥35 kg/m2 with at least one obesity-related comorbidity; multi-disciplinary team pre-surgical evaluation of the medical and psychological conditions that could interfere with health, weight loss outcome, or follow-up compliance 3. Among 98 candidates, 40 (41%) subjects underwent a bariatric procedure; 90% (36) underwent laparoscopic sleeve gastrectomy (LSG). No serious adverse events (SAE) were observed after surgery up to 12 months. The mean baseline BMI was 44.4 kg/m2 (±5.2), with a decrease of 9.7 kg/m2 (±3.5) and 13.3 kg/m2 (±5.5) at 6 and 12 months, respectively. The Percent Excess Weight Loss (%EWL) and Percent Total Body Weight Loss (%TBWL) were 47.8 (±17.7), 61.2 (±27.6) and 21.9 (±7.5), 27.6 (±10) at 6 and 12 months, respectively. Moreover, mean serum glucose levels reduced from 110.6 (±35.5) mg/dL at baseline to 90.4 mg/dL (±14.8) and 88.3 mg/dL (±12.7) after 6 and 12 months. Detailed data are shown in the table 4. Our multidisciplinary experience in bariatric patient management demonstrates that a proper pre-surgical selection of candidates and a regular follow up are effective in obtaining a substantial weight loss, preventing SAE, and ensuring long-term compliance in order to avoid weight regain and malnutrition. 1-SICOB